Hepatic Encephalopathy - 32 Studies Found

Completed : Rifaximin in Minimal Hepatic Encephalopathy
: Hepatic Encephalopathy
: 2007-09-20
:
  • Drug: Rifaximin 550mg BID rifa
Terminated : The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
: Hepatic Encephalopathy
: 2013-05-01
: Drug: Rifaximin Participants in Phase B will be administered 550 mg of Rifaximin two times a day for 14
Completed : Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
: Hepatic Encephalopathy
: 2010-04-23
:
  • Drug: VSL#3 VSL#3® is mad
Completed : Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
: Hepatic Encephalopathy
: 2010-08-02
:
  • Drug: Lactulose In the Gp-L gr
Completed : The Effects of Nitazoxanide in Hepatic Encephalopathy
: Hepatic Encephalopathy
: 2015-01-06
:
  • Drug: Nitazoxanide 500 mg nita
Completed : Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
: Hepatic Encephalopathy
: 2010-08-09
:
  • Drug: Lactulose will receive 3
Not yet recruiting : Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
: Covert Hepatic Encephalopathy
: 2017-01-30
: Drug: Rifaximin The investigators use low-dose rifaximin for the treatment of patients with covert hepat
Terminated : Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
: Hepatic Encephalopathy
: 2008-01-09
:
  • Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%

Completed : Cerebrovascular Reactivity in Hepatic Encephalopathy
: Hepatic Encephalopathy
: 2010-03-30
Completed : Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
: Hepatic Encephalopathy
: 2008-08-21
:
  • Drug: L-ornithine-L-aspartate and lactulose

Next >>>